GEDEON RICHTER ADR 144A 

$0
80
+$0+0% Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jun 25
$1.44
Jun 24
$1.21
Jun 23
$1.13
Jun 22
$0.61
Jun 21
$0.79
10Y Growth
18.57%
5Y Growth
12.7%
3Y Growth
8.38%
1Y Growth
N/A

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.99
1.33
1.66
1.99
Expected EPS
N/A
Actual EPS
N/A

Financials

19.58%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
2.29BRevenue
449.25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GEDRY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Gedeon Richter in various therapeutic areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Gedeon Richter's offerings, especially in women's healthcare and central nervous system drugs.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a leading generic and specialty pharmaceutical company that competes with Gedeon Richter in the generics market and in developing specialty medicines.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Gedeon Richter in several therapeutic areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the pharmaceuticals industry, focusing on immunology, oncology, neuroscience, and virology, areas where Gedeon Richter also has significant interests.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that compete with Gedeon Richter's product portfolio.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global healthcare leader that offers a broad range of pharmaceuticals, competing with Gedeon Richter in areas like central nervous system and cardiovascular diseases.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a science-led global healthcare company that competes with Gedeon Richter in developing and marketing medications and vaccines.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a diversified healthcare company that produces pharmaceuticals, medical devices, and consumer health products, competing across multiple segments with Gedeon Richter.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Gedeon Richter in developing new medicines in oncology, cardiovascular, renal & metabolism, and respiratory.

About

Pharmaceuticals: Other
Health Technology
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women's healthcare, cardiovascular, and central nervous system. The company women's healthcare products include contraceptives, endometriosis, fertility, menopause, vaginal infections, and preparations used for the treatment of uterine fibroids. It also offers central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Escapelle and Postinor, an emergency contraceptive pill; Panangin and Folik for pregnancy supplementation; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Groprinosin for antiviral and immunostimulant; Moilec for back and joint pain; Fasconal, a pain relief tablet; Magnezin, a magnesium supplementation; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat, anti-inflammatory, local anesthetic, and before and after oral surgery spray; Lordestin for allergy; and Curiosin for wound care. Further, it provides financial and accounting, social welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.
Show more...
CEO
Mr. Gabor Orban
Employees
10943
Country
HU

Listings

0 Comments

Share your thoughts

FAQ

What is GEDEON RICHTER ADR 144A stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange GEDEON RICHTER ADR 144A stocks are traded under the ticker GEDRY.
What is GEDEON RICHTER ADR 144A revenue for the last year?
GEDEON RICHTER ADR 144A revenue for the last year amounts to 2.29B USD.
What is GEDEON RICHTER ADR 144A net income for the last year?
GEDRY net income for the last year is 449.25M USD.
Does GEDEON RICHTER ADR 144A pay dividends?
Yes, GEDRY dividends are paid annual. The last dividend per share was 1.17 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does GEDEON RICHTER ADR 144A have?
As of April 03, 2026, the company has 10,943 employees.
When did GEDEON RICHTER ADR 144A complete a stock split?
The last stock split for GEDEON RICHTER ADR 144A was on July 23, 2013 with a ratio of 10:1.
Where is GEDEON RICHTER ADR 144A headquartered?
GEDEON RICHTER ADR 144A is headquartered in Budapest, HU.